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uis Pérez-Mañáa, Genis Cardonab,∗, Yolanda Pardo-Cladellasc,d,
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Abstract
Purpose:  To  validate  the  Spanish  Low  Vision  Qualify  of  Life  (SLVQOL)  questionnaire,  a  quality
of life  instrument  specifically  designed  for  patients  with  visual  impairment,  and  evaluate  its
psychometric  properties.
Methods:  The  study  included  170  visually  impaired  patients  and  195  healthy  subjects.  Par-
ticipants were  administered  the  SLVQOL,  the  NEI  VFQ-25,  and  the  EQ  5D-5L  questionnaires.
Reliability,  test--retest  reproducibility,  feasibility,  and  construct  validity  of  the  SLVQOL  were
assessed.  The  Generalized  Partial  Credit  Model  was  used  to  fit  the  data  and  the  performance
of each  item  was  characterized  using  category  response  curves  and  item  information.
Results: The  reliability  of  the  SLVQOL  was  0.981  (95%  CI:  0.978--0.985).  Test--retest  repro-
ducibility was  good  (  =  0.864,  P  <  .001).  A  cut-off  point  of  105  or  106  was  optimal  to  detect
visual impairment,  with  a  sensitivity  of  95.4%  and  a  specificity  of  91.8%.  Construct  validity  was
shown by  the  corresponding  convergence  or  divergence  correlations  between  the  score  of  the
SLVQOL and  its  dimensions  and  the  overall  and  partial  scores  of  the  NEI  VFQ-25  and  the  EQ  5D-
5L. Item  response  theory  analysis  showed  discrimination  and  information  parameters  ranging
from 0.539  to  3.063  and  from  −1.894  to  1.074,  respectively.∗ Corresponding author at: Genis Cardona Department of Optics and Optometry, Universitat Politècnica de Catalunya, Violinista Vellsolà,
7, E08222, Terrassa, Spain.
E-mail address: genis.cardona@upc.edu (G. Cardona).
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Conclusion:  The  SLVQOL  was  able  to  quantitatively  assess  and  identify  differences  in  the  quality
of life  among  patients  with  visual  impairment  and  normal  subjects.  The  evaluated  psychometric
properties  suggest  that  this  tool  has  excellent  validity,  internal  consistency,  and  reproducibility,
but may  benefit  from  a  reduction  of  the  number  of  items.
© 2021  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.U.  This  is  an























































































0.52  logMAR),  those  having  low  vision  (values  equal  or  infe-ntroduction
ith  a  progressively  ageing  population,  the  prevalence  of
lindness  and  visual  impairment  has  increased  worldwide
n  the  recent  decades.1 Vision  loss  and  visual  impairment
ave  been  associated  with  conditions  such  as  age-related
acular  degeneration,  diabetic  retinopathy,  myopia,  glau-
oma,  or  cataracts,  which  are  more  prevalent  in  developing
ountries.2,3 Visual  care  providers  specialized  in  low  vision
ommonly  evaluate  distant  and  near  visual  acuity,  reading
peed,  comfortable  reading  time  and  fluidity,  and  contrast
ensitivity.4 These  measurements,  however,  do  not  provide
nformation  regarding  the  actual  perception  of  patients
f  their  conditions  or  their  limitation  to  perform  daily-
ife  activities,  which  may  present  notable  discrepancies  as
ssessed  by  clinical  tests.5,6 Patient  reported  outcomes  are
ssential  to  improve  communication  between  patients  and
rofessionals,  and  to  assess  the  effectiveness  of  current  and
uture  treatments.  Improving  or  maintaining  the  quality  of
ife  of  patients  should  be  the  objective  of  any  treatment.
ence  their  opinion  and  perspective  should  be  considered
hen  deciding  an  appropriate  treatment.
Since  the  1980s,  there  has  been  a  rapid  prolifera-
ion  of  new  quality  of  life  instruments  and  a  flourishing
iterature  on  patient  reported  outcomes  in  the  field  of
ision  and  ocular  health.  Vision-related  quality  of  life
as  been  assessed  with  non-vision  specific  questionnaires
uch  as  the  EuroQol  Research  Foundation  EQ  5D-5L,7 with
eneric  instruments  developed  to  cover  multiple  common
ision  threatening  conditions  that  include  the  National  Eye
nstitute  Visual  Function  Questionnaire  (NEI  VFQ-25)8 or
ith  questionnaires  designed  specifically  for  patients  with
elected  conditions.9--16 Other  researchers  have  developed
ools  to  assess  quality  of  life  of  patients  with  low  vision.17--20
he  LVQOL,  developed  in  English  by  Wolffsohn  and  Cochrane
n  2000,20 is  currently  one  of  the  most  widely  used  ques-
ionnaires  by  researchers  in  the  field  of  low  vision.  It  has
een  translated  to  and  validated  in  Chinese,21 Thai,22 and
urkish.23 Recently,  it  has  also  been  translated  into  Span-
sh  by  some  of  the  authors  of  this  manuscript  following  the
ethodology  proposed  by  the  International  Society  for  Phar-
acoeconomics  and  Outcomes.24,25
The  aim  of  the  present  study  was  to  validate  the  Span-
sh  version  of  the  LVQOL  in  a  sample  of  patients  with
ision  impairment,  and  a  control  group  of  healthy  subjects,
nd  thereby  assess  its  psychometric  properties  in  terms  of
eliability,  validity  and  feasibility.  In  addition,  the  contribu-
ion  of  individual  items  to  the  measurement  of  the  latent





esponse  theory  (IRT)  was  employed  to  investigate  item
iscrimination  and  information.  Indeed,  IRT,  and  Rasch  psy-
hometric  assessments  in  general,  are  currently  considered
uperior  to  Classical  Test  Theory  (CTT)  based  methods,  but
ay  provide  a  more  complex  interpretative  challenge  to
ome  clinicians.  Therefore,  the  most  significant  results  from
TT  and  IRT  analyses  are  presented.  The  score  of  the  Span-
sh  LVQOL  in  this  sample  of  patients  was  compared  with  that
f  a  non-vision  specific  questionnaire  (EQ  5D-5L)  and  with
hat  of  a vision-related,  generic  instrument  (NEI  VFQ-25),  to
llow  testing  for  construct  validity  in  terms  of  convergence,
s  well  as  divergence  relationships.
aterial and methods
 quantitative,  cross-sectional,  and  multicentre  study  was
onducted  on  participants  attending  a  public  hospital  and  a
rivate  clinic  in  Barcelona.
ubjects
 total  of  365  consecutive  patients  participated  in  the
tudy  in  order  to  replicate  the  original  work  of  Wolffsohn
nd  Cochrane.20 The  study  populations  were  recruited  from
atients  attending  ophthalmologic  consultation  at  Hospital
e  la  Esperanza,  Parc  de  Salut  Mar,  a  public  hospital  in
arcelona  (n  =  257)  and  from  Institut  Català  de  la  Retina----a
rivate  ophthalmology  clinic  located  in  Barcelona  (n  =  108).
Patients  from  both  groups  were  included  in  the  study  if
hey  had  stable  visual  parameters,  defined  by  the  absence  of
 clinically  significant  change  in  visual  acuity  (less  than  0.1
ogMAR)  in  the  last  six  months.  Patients  with  visual  impair-
ent  were  included  in  the  study  if  their  best-corrected
istance  visual  acuity  in  the  best  eye  was  equal  or  infe-
ior  to  0.30  logMAR  or  0.52  logMAR  when  recruited  from
 public  hospital  or  a  private  clinic,  respectively.  Healthy
atients  from  both  institutions  were  included  if  they  exhib-
ted  a  best-corrected  distance  visual  acuity  equal  or  superior
o  0.10  logMAR  in  the  worst  eye.  According  to  the  criteria  set
y  International  Classification  of  Diseases  (ICD-10)26 and  the
rganización  Nacional  de  Ciegos  Españoles  (ONCE),  patients
rom  the  visual  impairment  group  were  classified  as  those
ith  mild  visual  impairment  (best-corrected  visual  acuity  in
he  best  eye  equal  or  inferior  to  0.30  logMAR  and  superior  toior  to  0.52  logMAR  and  superior  to  1.00  logMAR),  or  those
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This  study  was  conducted  in  accordance  with  the  latest
ersion  of  the  Declaration  of  Helsinki,  following  approval  of
he  ethical  review  board  of  the  Parc  de  Salut  Mar  and  the
esearch  Commission  of  the  Institut  Català  de  la  Retina.  A
igned  informed  consent  was  obtained  from  all  the  partici-
ants,  prior  to  their  enrolment  in  the  study.
uestionnaires
hree  different  quality  of  life  questionnaires  were  admin-
stered:  the  LVQOL,  the  NEI  VFQ-25  and  the  EQ  5D-5L.
he  LVQOL  questionnaire  consists  of  25  items  grouped  in
our  dimensions----Far vision,  mobility,  and  lighting,  includ-
ng  elements  such  as  ‘‘to  watch  television  (distinguishing
mages),’’  Adaptation,  comprising  of  elements  such  as
‘unhappy  with  your  situation  in  life,’’  Reading  and  precision
ork,  that  includes  items  such  as  ‘‘to  read  labels  (for  exam-
le,  medicine  containers),’’  and  Activities  of  daily  life,
omposed  of  items  such  as  ‘‘to  read  your  own  letter.’’20,27
he  response  options  range  from  0  to  5  (5  steps)  with  0  indi-
ating  that  the  patient  can  no  longer  perform  the  activity
ue  to  their  vision  impairment,  and  5  denoting  the  absence
f  sight-related  difficulty  with  the  task.  Patients  may  also
ark  a  task  as  ‘‘N/A’’  on  the  questionnaire  implying  that
t  is  not  performed  for  non-vision  related  reasons.  A  single
verall  score  is  obtained  by  adding  the  numerical  score  for
ach  answer  in  the  items  (an  answer  marked  as  N/A  is  allo-
ated  the  average  score  of  the  questionnaire  to  avoid  bias
f  the  results)  and  ranges  between  0  and  125.  The  recent
panish  translation  of  this  questionnaire  (SLVQOL)  was  used
n  this  study.24
Despite  a  certain  lack  of  consensus,  the  NEI  VFQ-25  is
urrently  considered  the  gold  standard  in  the  field  of  vision
y  many  researchers.8 It  was  developed  from  various  vision
elated  functional  groups,  including  patients  with  glaucoma,
acular  degeneration,  cataracts,  and  other  pathologies,
ith  the  aim  of  obtaining  a  universal  tool  that  could  be
mployed  in  all  patients  with  a  visual  deficit  regardless  of
ause.  In  its  original  version  (NEI-VFQ),  this  instrument  con-
isted  of  51  items,  currently  reduced  to  25  items,  grouped  in
3  dimensions  that  include  General  health, General  vision,
cular  pain,  Near  vision, Distance  vision, Vision-specific
ocial  functioning, Vision-specific  mental  health, Expecta-
ions  for  visual  function,  Vision-specific  role  functioning,
ependency  due  to  vision, Driving, Peripheral  vision,  and
olor  vision. A  score  may  be  obtained  for  vision-related
uality  of  life  for  each  of  the  dimensions  ranging  from  0
worst)  to  100  (best),  and  an  overall  score  can  also  be  cal-
ulated.  The  validated  Spanish  version  of  the  NEI  VFQ-25
as  used  in  this  study.28
The  EQ  5D-5L  is  a  general  health  econometric  instru-
ent  widely  used  in  population  surveys,  including  the
ational  Health  Survey  in  Spain,  the  Catalan  Health  Sur-
ey,  and  the  English  National  Health  Service,  to  monitor  the
mpact  of  certain  pathologies.7 It  explores  five  dimensions
Mobility,  Self-care,  Usual  activities,  Pain/discomfort,  and
nxiety/depression)  at  five  graded  levels  ranging  from  ‘‘no
roblem  in  that  dimension  to  ‘‘extreme  problems.’’  It  also
ncludes  a  final  question  with  a  Visual  Analogue  Scale  in
hich  patients  must  rate  their  current  health  status  from







xx  (xxxx)  xxx--xxx
ealth  status).  The  validated  Spanish  version  of  the  EQ  5D-5L
as  used  in  this  study.29
ethodology
atients  underwent  a  complete  anamnesis,  an  optomet-
ic,  and  an  ophthalmological  examination  (visual  acuity,
lit-lamp  examination,  intraocular  pressure  assessment  and
undus  examination  under  dilation).  The  sociodemographic
nd  visual  information  documented  for  the  purpose  of
his  study  included  age,  sex,  highest  achieved  educational
evel,  living  status  (whether  patients  lived  alone),  and  best-
orrected  distance  visual  acuity  of  the  best  and  worst  eye.
atients  from  the  public  hospital  sub-sample  responded  to
hree  questionnaires  (SLVQOL,  NEI  VFQ-25  and  EQ  5D-5L)
dministered  in  a  random  order  through  a  telephone  inter-
iew.  Patients  from  the  private  clinic  completed  the  SLVQOL
lone  during  a  face-to-face  interview.  In  addition,  to  evalu-
te  the  test--retest  reproducibility  of  SLVQOL,  this  tool  was
e-administered  to  119  patients  with  visual  impairment  at
he  public  hospital  approximately  15  days  after  the  first
dministration.  Only  responses  from  patients  providing  a
egative  answer  to  the  question  ‘‘Has  your  vision  changed
ince  you  completed  the  first  questionnaire?’’  were  included
n  the  reproducibility  analysis  (n  =  73).
tatistical  analysis
he  IBM  Statistical  Package  for  the  Social  Sciences  (SPSS)
tatistics  v.25  (IBM  Corp.  NY,  US),  Stata/IC  v.13.1  (StataCorp
LC,  TX,  US),  and  R  v.3.5.1  (R  Foundation  for  statisti-
al  computing,  Vienna,  Austria)  were  used  for  statistical
nalysis.  For  statistical  purposes,  visual  acuity  outcomes
ere  transformed  from  decimal  notation  to  logMAR  (2  log-
AR  corresponded  to  being  able  to  count  fingers  at  two
eet;  3  logMAR  corresponded  to  being  able  to  detect  hand
ovement  at  two  feet).  The  Shapiro-Wilk  test  was  used
o  test  the  normality  of  the  quantitative  numerical  data
ecorded  for  the  assessed  parameters.  Sociodemographic
nd  clinical  data  of  the  whole  sample  and  of  each  sub-
ample  was  presented  as  absolute  and  relative  frequencies,
ean  ±  standard  deviation  (SD),  or  range  when  appropri-
te.  For  inferential  statistics,  the  Student’s  t-test  was  used
or  quantitative  variables.  When  normality  could  not  be
ssumed,  the  corresponding  nonparametric  test  was  per-
ormed.  For  categorical  variables,  the  Chi-squared  test  or
he  Fisher’s  exact  test  was  used  based  on  the  fulfilment  of
he  criteria  for  the  use  of  these  tests.  Receiver  operating
urve  (ROC)  analysis  was  used  to  determine  the  optimal  cut-
ff  point  to  define  visual  impairment  in  terms  of  sensitivity
nd  specificity.
The  reliability  of  the  SLVQOL  was  estimated  from
he  whole  sample  using  the  Cronbach’s  alpha,  and  the
est--retest  reproducibility  was  determined  by  employing
he  Spearman  correlation  coefficient  ()  analysis.  Con-
truct  validity  was  investigated  through  correlation  analysis
etween  clinical  and/or  sociodemographic  variables,  the
cores  of  each  of  the  dimensions  of  the  SLVQOL,  and  between
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L.  Pérez-Mañá,  G.  Cardo
Sample  size  was  determined  using  the  freely
vailable  online  sample  size  and  power  calculator
RANMO  (v7.12,  April  2012;  https://www.imim.cat/
fertadeserveis/software-public/granmo/;  last  accessed
eptember  2019).  An  LVQOL  score  of  100.3  ±  20.8
mean  ±  SD)  was  defined  as  derived  from  previous  research
ndings  on  healthy  patients,20 and  a  change  of  10%  or
ore  was  assumed  in  patients  with  visual  impairment.
hus,  a  minimum  sample  size  of  126  participants  from  each
roup  was  determined,  considering  a  type  I  error  of  0.05
alpha)  and  a  statistical  power  of  80%  (1-beta).  P  <  .05  was
onsidered  as  the  cut-off  point  of  statistical  significance.
As  noted  above,  the  LVQOL  was  originally  intended  as
 single  dimension  questionnaire  providing  an  overall  score
rom  the  summation  of  partial  item  scores.  On  that  premise,
he  translated  SLVQOL  was  considered  a  mono-dimensional
cale  and  item  response  theory  (IRT)  analysis  was  employed
o  determine  the  contribution  of  individual  items  to  the
easurement  of  the  latent  trait  (defined  as  the  depen-
ent  variable  vision  related  qualify  of  life).  Firstly,  factor
nalysis  was  used  to  estimate  the  degree  of  association
f  items  with  the  latent  trait,  considering  acceptable  val-
es  those  over  0.4.30 Secondly,  a  Generalized  Partial  Credit
odel  (GPCM)31 was  used  to  evaluate  item  discrimination
apacities,  that  is,  measurement  quality,  category  response
hresholds  (to  assess  monotonicity  or  uniformity),  as  well
s  item  information.  The  GPCM  was  fitted  to  the  data  via
aximum  likelihood  estimation  using  the  mirt  package  for
.32 Model  fit  was  assessed  using  Zh and  S--X2 goodness-of-fit
tatistics,  calculated  in  mirt.33 Briefly,  the  Zh index  is  a  nor-
alized  measure  of  the  likelihood  of  obtained  responses  to
n  item  and  it  approximately  follows  a  normal  distribution,
ith  values  ranging  from  −1  to  1.  In  addition,  an  S--X2 P  <  .05
s  indicative  of  poor  fit.  Finally,  Category  Response  Curves
CRCs),  which  describe  the  probability  of  observing  a  partic-
lar  response  as  a  function  of  the  latent  trait  (in  this  case,
uestionnaire  score  on  vision  related  quality  of  life),  and
tem  information  plots,  were  generated  with  mirt  to  reflect
he  fitted  model  parameters.
esults
he  study  sample  from  the  public  hospital  included  119
atients  (46.3%)  with  visual  impairment  and  138  healthy
ubjects  (53.7%)  as  a  control  group,  whereas  the  sample
rom  the  private  clinic  comprised  of  51  patients  (47.2%)
ith  visual  impairment  and  57  healthy  subjects  (52.8%).  The
ociodemographic  characteristics  of  the  365  patients  who
ompleted  the  SLVQOL  are  shown  in  Table  1  and  are  clas-
ified  based  on  the  centre  of  recruitment,  and  the  visual
ealth  status.  The  age  of  the  patients  was  78.8  ±  10.0  years
mean  ±  SD)  for  the  visual  impairment  group  (n  =  170)  of
hom  47.7%  were  men  and  52.3%  were  women.  For  the
roup  of  healthy  participants,  the  mean  age  was  68.7  ±  11.5
ears  (n  =  195)  and  comprised  of  42.1%  men  and  57.9%
omen.  The  gender  distribution  was  similar  between  both
roups  (P  >  .05).  Patients  with  visual  impairment  were  sig-
ificantly  older  than  the  healthy  patients  (P  <  .001).  Of  all
atients  with  visual  impairment,  32.4%  (n  =  55)  were  clas-
ified  as  having  mild  visual  impairment,  38.8%  (n  =  66)  as
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xpected,  given  the  inclusion  criteria,  patients  from  the
rivate  clinic  had  characteristically  higher  educational  lev-
ls  and  more  severe  forms  of  visual  impairment  than  those
ecruited  from  the  public  hospital.  Patients  with  visual
mpairment  showed  a  significantly  lower  educational  level
han  healthy  subjects  (P  <  .001).
Patients  with  visual  impairment  had  dry  (25.3%,  n  =  43)  or
xudative  (32.9%,  n  =  56)  age-related  macular  degeneration,
ataracts  (28.2%,  n  =  48),  glaucoma  (11.2%,  n  =  19),  dia-
etic  retinopathy  (8.8%,  n  =  15)  or  other  pathologies  (12.9%,
 =  22).  Table  2  shows  the  visual  function  of  study  subjects
elonging  to  both  groups  represented  as  the  geometric  mean
f  the  best-corrected  distance  visual  acuity  of  the  best
nd  worst  eyes  (in  logMAR  notation).  A statistically  signifi-
ant  difference  in  visual  function  was  observed  between  the
isual  impairment  group  and  the  healthy  group  in  the  entire
tudy  population  and  also  by  considering  the  two  recruit-
ent  centres  separately  (P  <  .001  for  all).
Table  3  depicts  the  overall  score  of  the  SLVQOL,  as  well
s  the  score  of  each  of  the  four  dimensions  of  the  instru-
ent,  split  by  visual  health  status  and  by  recruitment.  All
LVQOL  scores  (overall  and  for  each  dimension)  were  sig-
ificantly  lower  in  the  visual  impairment  group  than  in  the
ealthy  group  (P  <  .001  for  all).  As  a  whole,  patients  with
isual  impairment  had  a  SLVQOL  score  of  66.9  ±  23.2,  which
as  50  points  lower  than  the  score  of  117.2  ±  6.7  in  the
ealthy  group.  Of  the  four  dimensions  of  the  SLVQOL,  the
argest  difference  between  groups  was  detected  for  Read-
ng  and  precision  work, followed  by  Activities  of  daily  life.
uestionnaire  scores  in  the  public  hospital  sub-sample  were
ignificantly  higher  than  those  obtained  from  the  private
linic  setting  (P  <  .001  for  all),  except  for  the  dimension
eading  and  precision  work. In  general,  patients  from  the
rivate  clinic  reported  poorer  levels  of  quality  of  life,
elated  to  lower  visual  acuity  and  higher  level  of  visual
mpairment.  The  outcomes  of  the  NEI  VFQ-25  and  the  EQ
D-5L  are  provided  as  supplementary  material.
The  average  SLVQOL  score  obtained  by  patients  with
isual  impairment  according  to  their  classification  into
ild  visual  impairment,  low  vision  and  legal  blindness  is
resented  in  Table  4  and  shown  in  Fig.  1.  A  not  statis-
ically  significant  tendency  for  higher  quality  of  life  was
ound  in  patients  with  mild  visual  impairment  than  those
ith  low  vision  (score  difference  of  6.86,  P  =  .09).  In  con-
rast,  patients  with  low  vision  had  a  significantly  higher
LVQOL  score  than  those  with  legal  blindness  (score  dif-
erence  of  10.94,  P  =  .006).  Similarly,  patients  with  mild
isual  impairment  obtained  a  significantly  higher  score  than
hose  classified  as  legally  blind  (score  difference  of  17.81,
 <  .001).
Statistically  significant  moderate  correlations  were
bserved  between  best-corrected  distance  visual  acuity
f  the  best  (r  =  −0.404,  P  <  .001)  and  worst  (r  =  −0.406,
 <  .001)  eyes,  with  the  SLVQOL  score  of  patients  with  visual
mpairment.  The  highest  correlation  between  visual  acu-
ty  and  SLVQOL  scores  (r  =  −0.473,  P  <  .001)  was  obtained
hen  considering  the  weighted  arithmetic  mean  of  the  best-
orrected  visual  acuity  of  both  eyes  (75%  best  eye  and  25%
orst  eye).  ROC  analysis  revealed  a  cut-off  score  of  105
r  106  as  optimal  for  the  classification  of  visually  impaired
atients  and  healthy  subjects,  with  a  sensitivity  of  95.4%
nd  a specificity  of  91.8%.
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Table  1  Demographic  characteristics  of  the  visual  impairment  and  healthy  groups  based  on  recruitment  centre  (public  hospital
and private  clinic).
Public  hospital Private  clinic Overall
Visual  impairment  Control  Visual  impairment  Control  Visual  impairment  Control
n  119  (46.3) 138  (53.7) 51  (47.2) 57  (52.8)  170  (46.6)  195  (53.4)
Mild visual  impairment 48  (40.3) 7  (13.7) 55  (32.4)
Low vision  46  (38.7)  20  (39.2)  66  (38.8)
Legal blindness  25  (21.0)  24  (47.1)  49  (28.8)
Age (years)  79.0  ±  8.1  73.2  ±  5.6  78.4  ±  13.5  57.8  ±  14.6  78.8  ±  10.0  68.7  ±  11.5
Significance P  <  .001  P  <  .001  P  <  .001
Male 56  (47.1)  59  (42.8)  25  (49.0)  23  (40.4)  81  (47.7)  82  (42.1)
Female 63  (52.9)  79  (57.2)  26  (51.0)  34  (59.6)  89  (52.3)  113  (57.9)
Significance P  >  .05  P  >  .05  P  >  .05
Without studies  35  (29.4)  15  (10.9)  8  (15.7)  1  (1.8)  43  (25.3)  16  (8.3)
Elementary school  67  (56.3)  68  (49.3)  24  (47.1)  6  (10.5)  91  (53.5)  74  (37.9)
High school  11  (9.2)  26  (18.8)  11  (21.5)  21  (36.8)  22  (12.9)  47  (24.1)
University or  higher  6  (5.1)  29  (21)  8  (15.7)  29  (50.9)  14  (8.3)  58  (29.7)
Significance P  <  .001  P  <  .001  P  <  .001
Lives alone 39  (32.8) 36  (26.1)  9  (17.6)  8  (14.0)  48  (28.2)  44  (22.6)
Does not  live  alone 80  (67.2)  102  (73.9)  42  (82.4)  49  (86.0)  122  (71.8)  151  (77.4)
Significance P  <  .001 P  <  .001  P  <  .001
Categorical variables are expressed as number (%) and continuous numerical variables are expressed as mean ± standard deviation.
Student’s t-test was conducted for continuous numerical variables and the Chi square test and the Fisher’s exact test for categorical
variables. P < 0.05 was considered statistically significant.
Table  2  Visual  function  characteristics  of  the  visual  impairment  and  healthy  groups  shown  as  best-corrected  distance  visual
acuity of  best  and  worst  eyes  (logMAR  notation).














0.575  0.061  0.901  0.108  0.655  0.065
Range 0.3  to  2  −0.079
to  0.155
0.5  to  3  −0.1  to
0.2
0.3  to  3  −0.1  to
0.2
Significance  P  <  .001  P  <  .001  P  <  .001
Best-corrected
distance visual




1.050  0.073  1.670  0.159  1.200  0.079
Range 0.3  to  3  −0.079
to  0.222
0.7  to  3  −0.1  to
0.2
0.3  to  3  −0.1  to
0.222



















Visual acuity is shown as geometric mean and range (minimum 
P < 0.05 was considered statistically significant.
eliability
he  global  reliability  of  the  SLVQOL,  estimated  by  Cron-
ach’s  alpha  for  the  entire  study  sample,  was  0.981
95%  CI:  0.978--0.985).  The  mean  values  for  each  of  the
our  original  dimensions  were  calculated  as  0.971  (95%
I:  0.965--0.976)  for  Far  vision,  mobility  and  lighting,
.857  (95%  CI:  0.824--0.885)  for  Adaptation, 0.970  (95%  CI:
.964--0.976)  for  Reading  and  precision  work, and  0.953
95%  CI:  0.943--0.962)  for  Activities  of  daily  living. The
est--retest  reproducibility  was  assessed  for  a  sample  of  73






aximum). Student’s t-test was used to compare the results and
heir  vision.  On  performing  a retest  after  19.5  days  (±5.07
ays),  the  calculated  Spearman  correlation  coefficient    was
.864  (P  <  .001).
easibility
easibility  explored  the  practicality  of  questionnaire  admin-
stration.  The  time  taken  to  administer  the  questionnaire  for
he  group  with  visual  impairment  at  the  public  hospital  (tele-
hone  interview)  was  393.5  ±  73.1  s (95%  CI:  274--600  s).  This
as  much  longer  than  that  taken  for  subjects  attending
he  private  clinic  (face-to-face  interview)  (290.0  ±  68.7  s;
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L.  Pérez-Mañá,  G.  Cardona,  Y.  Pardo-Cladellas  et  al.
Table  3  Spanish  Low  Vision  Quality  of  Life  Questionnaire  (SLVQOL)  scores  (overall  and  for  each  dimension)  of  the  study  sample
based on  their  visual  health  status  (visual  impairment  and  healthy)  and  recruitment  centre  (public  hospital  and  private  clinic).
SLVQOL  score
Mean  ±  SD  Mean  ±  SD  Difference  Significance
SLVQOL
Visual  impairment  (Public  hospital  vs  Private  clinic)  71.3  ±  25.5  56.7  ±  11.6  14.6  P  <  .001
Visual impairment  vs  healthy  (both  centres)  66.9  ±  23.2  117.2  ±  6.7  50.3  P  <  .001
Far vision,  mobility  and  lighting
Visual  impairment  (Public  hospital  vs  Private  clinic)  75.3  ±  23.7  58.0  ±  14.0  17.3  P  <  .001
Visual impairment  vs  healthy  (both  centres)  70.1  ±  20.8  115.5  ±  7.3  45.4  P  <  .001
Adaptation
Visual impairment  (Public  hospital  vs  Private  clinic) 34.5  ±  10.2  27.1  ±  8.8  7.4  P  <  .001
Visual impairment  vs  healthy  (both  centres)  32.3  ±  9.8  45.9  ±  3.0  13.6  P  <  .001
Reading and  precision  work
Visual  impairment  (Public  hospital  vs  Private  clinic)  43.8  ±  38.2  40.2  ±  14.9  3.6  P  =  .37
Visual impairment  vs  healthy  (both  centres)  42.7  ±  31.2  114.5  ±  10.4  71.8  P  <  .001
Activities of  daily  life
Visual  impairment  (Public  hospital  vs  Private  clinic) 68.5  ±  34.9  49.2  ±  20.1  19.3  P  <  .001
Visual impairment  vs  healthy  (both  centres) 62.7  ±  30.5 122.6  ±  6.1  59.9  P  <  .001
SD = Standard deviation. The score of the subscales has been transformed into a scale from 0 to 125 to aid in comparison. Student’s t-test
was used to compare the results and P < 0.05 was considered statistically significant.
Table  4  Spanish  Low  Vision  Quality  of  Life  Questionnaire  (SLVQOL)  score  of  patients  with  visual  impairment  (n  =  157)  according
to their  visual  acuity  (mild  visual  impairment,  low  vision  and  legally  blind).
SLVQOL  score
Mean  SD  Confidence  interval  (95%)  Minimum  Maximum
Mild  visual  impairment  72.4  *  24.1  25.2--119.6  43  122
Low vision  66.2 & 22.6  21.9--110.5  33  122
Legal blindness  55.3  *,  & 14.4  13.8--83.5  16  97







































SD = Standard deviation. The score of the SLVQOL may range from
* and & denote statistically significant differences between the gr
5%  CI:  182--525  s).  Administration  times  for  the  healthy
roup  were  345.8  ±  48.5  s  (95%  CI:  215--479  s)  at  the  pub-
ic  hospital  and  181.0  ±  40.4  s  (95%  CI:  110--275  s)  at  the
rivate  clinic.  For  both  recruitment  centres,  patients  with
isual  impairment  required  a  significantly  longer  time  than
ealthy  subjects  to  answer  the  questionnaire  (P  <  .001  for
ll).  Also,  face-to-face  interview  resulted  in  a  significan-
ly  shorter  administration  time  for  the  questionnaire  than
 telephone  interview  for  both  the  groups  (P  <  .001  for  all).
alidity
onvergent  correlations  were  found  between  the  dimen-
ions  Self-care  (r  =  0.41)  and  Usual  activities  (r  =  0.73)  of  the
Q  5D-5L  and  the  SLVQOL  scores.  The  rest  of  the  dimen-
ions  of  the  EQ  5D-5L  showed  divergent  correlations  with
he  SLVQOL.  Convergent  correlations  were  also  observed
etween  the  overall  score  of  the  SLVQOL  and  that  of  the
EI  VFQ-25,  as  well  as  between  the  scores  for  each  of  the
imensions  of  both  questionnaires  (r  ranged  from  0.58  to
.96).  However,  the  score  for  the  dimension  Ocular  pain






125. The lower the score, the lower the reported quality of life.
 (P < 0.05).
tem  response  analysis
utcomes  of  the  factor  analysis  and  the  GPCM  analysis  are
ummarized  in  Table  5. With  the  exclusion  of  Item  16,  fac-
or  loading  values  ranged  from  0.302  to  0.874,  with  only  four
tems  (4,  5,  13  and  14)  displaying  values  <0.4,  and  the  total
ariance  retained  by  the  single  dimension  was  40%.  Discrim-
nation  parameters  ranged  from  0.539  to  3.063,  with  seven
tems  presenting  values  inferior  to  1.  Information  parame-
ers  ranged  from  −1.894  to  1.074.  Only  six  items  presented
n  information  parameter  greater  than  0,  all  of  which  also
ad  discrimination  parameters  superior  to  1.  Overall,  good-
ess  of  fit  was  found  to  be  good,  with  all  items  showing  Zh
alues  between  0  and  1  and  with  only  two  items  displaying
--X2 P <  .05  (items  9  and  19).  Regarding  response  thresholds,
nly  11  items  did  not  show  any  degree  of  overlapping.
For  illustrative  purposes,  Fig.  2  displays  fitted  category
esponse  curves  and  item  information  for  items  10  and  15.
t  may  be  observed  that,  whereas  item  10  presents  no  over-
apping  and  well-ordered  category  responses,  and  an  item
nformation  peak  near  intermediate  scores  (item  informa-
ion  value  of  −0.421),  item  15  displays  overlapping  and










































Zh S-X2 S-X2 P
Item  1  0.607  1.301  −3.622  −0.655  0.119  1.575  2.519  −0.013  No  0.361  42.181  0.108
Item 2  0.523  1.045  −3.721  −0.870  −0.977  0.876  1.427  −0.653  Yes  0.265  44.085  0.167
Item 3  0.402  0.747  −3.446  −0.794  −2.164  1.381  0.359  −0.933  Yes  0.134  27.139  0.754
Item 4  0.378  0.695  −4.783  −2.692  −0.801  0.808  −0.430  −1.580  Yes  0.189  42.295  0.291
Item 5  0.320  0.574  −6.386  −0.679  1.127  2.461  1.933  −0.309  Yes  0.111  39.062  0.422
Item 6  0.707  1.702  −2.244  −0.628  0.005  0.865  0.988  −0.203  No  0.468  30.380  0.598
Item 7  0.874  3.063  −1.736  −0.728  −0.089  0.654  1.160  −0.148  No  0.927  19.383  0.778
Item 8  0.773  2.071  −2.848  −1.009  −0.613  0.587  0.545  −0.668  Yes  0.574  21.892  0.910
Item 9  0.572  1.188  −2.815  −2.058  −1.025  0.324  −0.003  −1.115  Yes  0.307  50.856  0.032
Item 10  0.747  1.910  −2.980  −0.941  0.000  0.552  1.263  −0.421  No  0.517  19.128  0.965
Item 11  0.789  2.183  −2.474  −0.672  0.021  0.687  1.421  −0.203  No  0.637  19.814  0.800
Item 12  0.783  2.142  −2.934  −0.557  −0.451  0.725  0.750  −0.493  No  0.753  28.912  0.574
Item 13  0.302  0.539  −6.525  −1.574  −0.779  0.968  −1.562  −1.894  Yes  0.176  50.179  0.311
Item 14  0.387  0.714  −5.938  −0.688  −0.579  0.510  0.312  −1.277  Yes  0.273  53.495  0.306
Item 15  0.489  0.955  −3.053  −0.981  −0.839  −0.219  −0.865  −1.191  Yes  0.385  34.390  0.720
Item 16  0.083  0.142  −15.979  −1.097  −2.585  −6.538  −7.824  −6.805  Yes  0.005  35.682  0.484
Item 17  0.671  1.539  −2.119  −0.512  −0.402  0.258  −0.194  −0.594  Yes  0.684  26.788  0.892
Item 18  0.726  1.797  −0.391  0.312  0.334  1.161  1.363  0.556  No  0.566  33.537  0.393
Item 19  0.651  1.460  −0.196  0.937  1.292  1.328  2.008  1.074  No  0.357  43.568  0.031
Item 20  0.713  1.730  −0.438  0.393  0.214  1.173  1.469  0.562  Yes  0.541  35.940  0.332
Item 21  0.566  1.167  −0.371  1.179  0.424  1.491  2.268  0.998  Yes  0.283  40.953  0.054
Item 22  0.745  1.903  −2.596  −0.592  −0.343  0.251  0.491  −0.558  No  0.752  44.077  0.140
Item 23  0.685  1.600  −0.772  0.216  0.259  1.075  0.939  0.343  Yes  0.511  38.582  0.232
Item 24  0.787  2.172  −1.497  0.030  0.201  0.284  1.004  0.005  No  0.541  24.200  0.450
Item 25  0.781  2.130  −2.401  −0.752  −0.702  0.516  0.909  −0.486  No  0.662  32.045  0.514
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Figure  1  Spanish  Low  Vision  Quality  of  Life  Questionnaire
scores for  each  visual  impairment  level.  Higher  values  of  SLVQOL























Figure  2  Fitted  category  response  curves  (top)  and  item  informatio
possible category  responses  ranging  from  ‘‘the  patient  can  no  longe
of sight-related  difficulty  with  the  task’’.
8
 PRESS
.  Pardo-Cladellas  et  al.
eak  of  −1.191.  Indeed,  GPCM  coefficients  of  this  item  range
rom  −3.053  to  −0.219,  measuring  only  latent  trait  values
f  patients  on  the  left  side.
iscussion
atient  reported  outcomes  are  essential  to  thoroughly  com-
rehend  the  health  status  of  patients  and  to  provide  the
est  possible  care.  Although  many  questionnaires  have
een  developed  to  assess  the  quality  of  life  of  patients
ith  ocular  and  visual  problems,  only  few  instruments  are
pecific  for  evaluating  low  vision  or  visual  impairment  in
atients.  Of  those  available,  the  LVQOL  has  been  docu-
ented  to  present  good  psychometric  properties.20,27 This
nstrument  was  developed  and  validated  in  English  language,
nd  subsequently  in  Thai,  Turkish,  and  Chinese.21--23 The
ecent  translation  and  cultural  adaptation  of  the  LVQOL  to
panish,24 which  is  the  second-most  spoken  native  language
fter  Mandarin  Chinese,  created  the  opportunity  to  design
he  present  validation  study.  The  new  tool  SLVQOL  will  be
seful  for  both  clinicians  and  researchers  to  assess  the  qual-
ty  of  life  of  their  Spanish-speaking  patients,  to  develop
uality  of  life  studies,  and  to  share  their  findings  with  the
nternational  community.
n  for  item  10  (left)  and  item  15  (right).  P1  to  P6  refer  to  the  six
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In  the  process  of  validating  a  new  instrument  it  is  useful
o  compare  it  with  the  gold-standard  in  the  field.  Unfor-
unately,  there  are  no  current  translated  and  validated
ow  vision  specific  quality  of  life  questionnaires  in  Spanish.
herefore,  to  assess  the  construct  validity  of  the  SLVQOL,
ts  results  were  compared  with  those  of  the  non-vision  spe-
ific  EQ  5D-5L  and  the  vision-related  generic  NEI  VFQ-25,
oth  of  which  have  been  translated  to  and  validated  in
panish.28,29 Construct  validity  was  evidenced  by  the  cor-
esponding  moderate  to  strong  convergent  and  divergent
orrelations  between  both----the  overall  scores  of  the  three
uestionnaires  and  of  their  respective  dimensions,  with  the
xception  of  the  dimension  Ocular  pain  in  NEI  VFQ-25.  The
imension  Ocular  pain  was  not  assessed  by  the  SLVQOL
s  none  of  the  most  frequent  causes  of  visual  impairment
age  related  macular  degeneration,  cataract,  myopia,  dia-
etic  retinopathy  or  glaucoma)  account  for  ocular  pain  in
atients.  The  outcomes  of  the  NEI  VFQ-25  and  the  EQ  5D-
L,  provided  as  supplementary  material,  were  comparable
o  those  previously  published  for  patients  with  low  vision
nd  visual  impairment.28,34
A  cut-off  score  of  105  or  106  was  found  to  be  opti-
al  to  discriminate  between  visual  impairment  and  healthy
atients.  The  good  classification  capabilities  found  in  this
tudy  are  promising  but  could  be  an  over-estimation  due  to
he  clear-cut  definition  of  cases  and  control  groups.  Ade-
uately  studies  designed  to  identify  patients  with  visual
mpairment  in  the  general  population  are  needed  to  eval-
ate  its  usefulness  as  a  screening  tool.
The  difference  of  50.3  points  in  the  SLVQOL  global  score
etween  patients  with  visual  impairment  and  healthy  sub-
ects  was  larger  than  the  difference  of  39.4  points  reported
y  Wolffsohn  and  Cochrane  in  their  original  study.20 The  lat-
er  documented  an  average  score  of  60.9  ±  25.1  for  patients
ith  visual  impairment,  which  was  lower  than  that  obtained
n  the  present  study  (66.9  ±  23.2).  The  partial  discrepancy
ith  the  Australian  cohort  thus  observed  could  be  owing  to
everal  reasons.  First,  the  differences  in  the  inclusion  crite-
ia  of  the  two  studies  accounted  for  a  better  average  visual
cuity  of  the  Australian  patients  (0.58  ±  0.35  logMAR),  as
ompared  to  the  Spanish  patients  in  this  study  (0.75  ±  0.43
ogMAR).  Moreover,  healthy  subjects  in  the  Australian  cohort
ere  age-matched  with  their  visually  impaired  counter-
arts,  whereas  the  sample  of  healthy  subjects  in  the  present
tudy  was  on  average  slightly  younger  than  the  visual  impair-
ent  group.  This  was  one  of  the  major  limitations  of  this
tudy,  which  may  have  contributed  to  the  overestimation
f  the  differences  in  SLVQOL  score  and  the  time  taken  to
dminister  the  questionnaire  for  both  groups.  In  addition,  it
ust  be  noted  that  visual  acuity  was  measured  in  decimal
otation  and  later  converted  to  logMAR  notation,  instead  of
easuring  it  on  a  logMAR  chart.  This  may  have  introduced
mall  errors  to  our  measurements,  as  decimal  visual  acuity
otation  does  not  present  homogeneous  steps.
One  finding  that  confirms  the  usefulness  of  a  quality  of
ife  specific  questionnaire  was  the  ability  of  the  SLVQOL
o  partly  discriminate  among  the  different  levels  of  visual
mpairment,  particularly  mild  visual  impairment  from  legal
lindness  and  low  vision  from  legal  blindness,  as  shown  in
ig.  1.  However,  the  outcome  of  the  GPCM  analysis  revealed
hat  a  single  dimension  approach  is  not  an  adequate  fit
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6)  with  a  discrimination  parameter  lower  than  1,  which
ould  suggest  excluding  them  of  the  scale  or  considering
 multi-dimensional  solution.  In  effect,  the  presence  of
ultidimensionality  in  questionnaires  may  prevent  correct
nterpretation  of  the  global  score,  as  more  than  one  latent
rait  is  being  assessed.  Also,  the  occurrence  of  overlapping
nd  disordered  category  responses  gives  support  to  a  revi-
ion  of  the  instrument  by  collapsing  categories  to  improve
tem  information.  Further  research  efforts  shall  be  devoted
n  this  direction,  which  may  lead  to  a  shorter  and  more
iscriminating  version  of  the  SLVQOL.
The  current  sample  size,  determined  by  calculation  and
ollowing  the  recommendations  of  one  of  the  authors  of  the
riginal  instrument  (J.S.W),  was  considered  sufficient  for
he  purpose  of  this  study  to  replicate  previous  validation
tudies  in  English  (278  visually  impaired  and  70  healthy),20
hinese  (100  visually  impaired  and  100  healthy),21 and  Turk-
sh  (378  visually  impaired).23 However,  sample  size  may  have
een  insufficient  for  the  dimensionality  assessment  of  the
uestionnaire,  which  may  require  a  sample  size  of  1000  or
ore  for  complex  IRT  models.35
In  this  study,  patients  were  recruited  from  two  differ-
nt  clinical  settings----a  large  public  hospital  (National  Health
ystem)  and  a  private  clinic.  Subjects  from  both  these
entres  mainly  differed  in  terms  of  degree  of  visual  impair-
ent,  educational  status,  income  (data  not  shown)  and  the
ode  of  questionnaire  administration  (telephone  interview
s  face-to-face  interview).  It  may  be  acknowledged  that  this
ampling  method  is  likely  to  have  introduced  some  unwanted
onfounding  variables  to  the  study,  which  may  influence
he  results,  particularly  the  absolute  questionnaire  scores.
owever,  for  the  purpose  of  validation,  a  larger,  heteroge-
eous  sample  was  preferred  in  order  to  accurately  reflect
he  behaviour  of  the  tool  in  a  general  population  scenario  in
hich  a  dispersion  of  all  the  previously  mentioned  socioeco-
omic  and  disease-related  parameters  is  present.  It  may  be
ssumed  that  although  a study  based  on  a  narrowly  defined
ample  may  lead  to  better  psychometric  properties  of  the
LVQOL,  nevertheless  its  results  would  be  less  suitable  to
xtrapolate  to  a  wider  population  of  patients  with  visual
mpairment.
The  values  of  Cronbach’s  alpha  for  the  entire  sample  and
or  each  of  the  four  dimensions  were  very  high  (>0.90).  Val-
es  between  0.8  and  0.9  are  ideal  and  denote  good  reliability
f  the  instrument,  while  values  over  0.9  may  be  an  indicator
f  redundancy  or  replication  of  items.36 This  would  advise,
s  a possible  line  of  future  work,  the  reduction  of  the  ques-
ionnaire,  which  would  also  result  in  shorter  administration
imes.
In  conclusion,  the  SLVQOL  was  able  to  quantitatively  and
eproducibly  assess  the  quality  of  life  in  patients  with  visual
mpairment  and  in  normal  subjects.  Additionally,  the  SLVQOL
isplayed  psychometric  properties  that  were  similar  to  or
uperior  to  the  original  version,  although  IRT  analysis  evi-
enced  the  need  to  structure  the  questionnaire  in  two  or
hree  well-defined  subscales  and  to  reconsider  including
ertain  items  that  may  be  unable  to  provide  significant  dis-
rimination.  The  results  of  the  present  study  suggest  that
he  SLVQOL  can  be  very  useful  in  future  studies  and  clini-
al  trials  to  precisely  and  reproducibly  assess  the  quality  of
ife  related  to  vision  impairment.  It  can,  thereby,  improve
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